Intrexon | XON - Market Capitalization


Intrexon reported $1.78B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
Amgen USD 195.44B 5.55B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 22.65B 3.92B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
MacroGenics USD 184M 82M Mar/2026
MannKind USD 1.32B 559M Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Xencor USD 1.19B 301M Jun/2026